Donor and host B cell-derived IL-10 contributes to suppression of graft-versus-host disease

European Journal of Immunology

Volumn 44, Issue 6, 2014, Pages 1857-1865

  Weber, Michael ^a   Stein, Pamela ^a   Prüfer, Steve ^a   Rudolph, Berenice ^a   Kreft, Andreas ^a   Schmitt, Edgar ^a   Bopp, Tobias ^a   Roers, Axel ^b   Schild, Hansjörg ^a   Fillatreau, Simon ^c   Radsak, Markus P ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

Author keywords

B cells; Graft versus host disease; IL 10

Indexed keywords

CD1D ANTIGEN; CD5 ANTIGEN; INTERLEUKIN 10; KIDNEY INJURY MOLECULE 1;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CELL ACTIVATION; CELL FUNCTION; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOKINE PRODUCTION; DONOR; FEASIBILITY STUDY; GRAFT VERSUS HOST REACTION; HOST CELL; IN VIVO STUDY; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

B CELLS; GRAFT-VERSUS-HOST DISEASE; IL-10;

ALLOGRAFTS; ANIMALS; B-LYMPHOCYTES; DENDRITIC CELLS; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; INTERLEUKIN-10; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; T-LYMPHOCYTES;

EID: 84901838956     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201344081     Document Type: Article

References (37)

1. Ferrara, J. L. M., Levine, J. E., Reddy, P. and Holler, E., Graft-versus-host disease. Lancet 2009. 373: 1550-1561.
2. Blazar, B. R., Murphy, W. J. and Abedi, M., Advances in graft-versus-host disease biology and therapy. Nat. Rev. Immunol. 2012. 12: 443-458.
3. Holler, E., Roncarolo, M. G., Hintermeier-Knabe, R., Eissner, G., Ertl, B., Schulz, U., Knabe, H. et al., Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation. Bone Marrow Transplant 2000. 25: 237-241.
4. Lin, M.-T., Storer, B., Martin, P. J., Tseng, L.-H., Gooley, T., Chen, P.-J. and Hansen, J. A., Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N. Engl. J. Med. 2003. 349: 2201-2210.
5. Zeller, J. C., Panoskaltsis-Mortari, A., Murphy, W. J., Ruscetti, F. W., Narula, S., Roncarolo, M. G. and Blazar, B. R., Induction of CD4+ T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-beta. J. Immunol. 1999. 163: 3684-3691.
6. Blazar, B. R., Taylor, P. A., Smith, S. and Vallera, D. A., Interleukin-10 administration decreases survival in murine recipients of major histocompatibility complex disparate donor bone marrow grafts. Blood 1995. 85: 842-851.
7. Blazar, B. R., Taylor, P. A., Panoskaltsis-Mortari, A., Narula, S. K., Smith, S. R., Roncarolo, M. G. and Vallera, D. A., Interleukin-10 dose-dependent regulation of CD4+ and CD8+ T cell-mediated graft-versus-host disease. Transplantation 1998. 66: 1220-1229.
8. Moore, K. W., O'Garra, A., de Waal Malefyt, R., Vieira, P. and Mosmann, T. R., Interleukin-10. Annu. Rev. Immunol. 1993. 11: 165-190.
9. Moore, K. W., Vieira, P., Fiorentino, D. F., Trounstine, M. L., Khan, T. A. and Mosmann, T. R., Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 1990. 248: 1230-1234.
10. Hoffmann, P., Ermann, J., Edinger, M., Fathman, C. G. and Strober, S., Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J. Exp. Med. 2002. 196: 389-399.
11. Tawara, I., Sun, Y., Liu, C., Toubai, T., Nieves, E., Evers, R., Alrubaie, M. et al., Donor- but not host-derived interleukin-10 contributes to the regulation of experimental graft-versus-host disease. J. Leukoc. Biol. 2012. 91: 667-675.
12. Markey, K., Banovic, T., Kuns, R., Olver, S., Don, A., Raffelt, N., Wilson, Y. et al., Conventional dendritic cells are the critical donor APC presenting alloantigen after experimental BMT. Blood 2009. 113: 5644-5649.
13. Rowe, V., Banovic, T., MacDonald, K. P., Kuns, R., Don, A. L., Morris, E. S., Burman, A. C. et al., Host B cells produce IL-10 following TBI and attenuate acute GVHD after allogeneic bone marrow transplantation. Blood 2006. 108: 2485-2492.
14. Lampropoulou, V., Hoehlig, K., Roch, T., Neves, P., Calderon-Gomez, E., Sweenie, C. H., Hao, Y. et al., TLR-activated B cells suppress T cell-mediated autoimmunity. J. Immunol. 2008. 180: 4763-4773.
15. Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D. and Anderton, S. M., B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 2002. 3: 944-950.
16. Kühn, R., Löhler, J., Rennick, D., Rajewsky, K. and Müller, W., Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993. 75: 263-274.
17. Berg, D. J., Davidson, N., Kühn, R., Müller, W., Menon, S., Holland, G., Thompson-Snipes, L. et al., Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J. Clin. Invest. 1996. 98: 1010-1020.
18. Tawara, I., Shlomchik, W. D., Jones, A., Zou, W., Nieves, E., Liu, C., Toubai, T. et al., A Crucial Role for Host APCs in the Induction of Donor CD4+CD25 +Regulatory T Cell-Mediated Suppression of Experimental Graft-versus-Host Disease. J. Immunol. 2010.
19. Neves, P., Lampropoulou, V., Calderon-Gomez, E., Roch, T., Stervbo, U., Shen, P., Kühl, A. A. et al., Signaling via the MyD88 Adaptor Protein in B Cells Suppresses Protective Immunity during Salmonella typhimurium Infection. Immunity 2010. 33: 777-790.
20. Ding, Q., Yeung, M., Camirand, G., Zeng, Q., Akiba, H., Yagita, H., Chalasani, G. et al., Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J. Clin. Invest. 2011. 121: 3645-3656.
21. Madan, R., Demircik, F., Surianarayanan, S., Allen, J. L., Divanovic, S., Trompette, A., Yogev, N. et al., Nonredundant roles for B cell-derived IL-10 in immune counter-regulation. J. Immunol. 2009. 183: 2312-2320.
22. Lee, S. M., Suen, Y., Qian, J., Knoppel, E. and Cairo, M. S., The regulation and biological activity of interleukin 12. Leuk. Lymphoma 1998. 29: 427-438.
23. Ma, F., Liu, X., Li, D., Wang, P., Li, N., Lu, L. and Cao, X., MicroRNA-466l upregulates IL-10 expression in TLR-triggered macrophages by antagonizing RNA-binding protein tristetraprolin-mediated IL-10 mRNA degradation. J. Immunol. 2010. 184: 6053-6059.
24. Kryczek, I., Wei, S., Zou, L., Zhu, G., Mottram, P., Xu, H., Chen, L. et al., Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells. J. Immunol. 2006. 177: 40-44.
25. Reichardt, W., Dürr, C., Elverfeldt von, D., Jüttner, E., Gerlach, U. V., Yamada, M., Smith, B. et al., Impact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell transplantation. J Immunol. 2008. 181: 4770-4779.
26. Wang, X., Hao, J., Metzger, D. L., Mui, A., Lee, I.-F., Akhoundsadegh, N., Ao, Z. et al., Endogenous expression of b7-h4 improves long-term murine islet allograft survival. Transplantation 2013. 95: 94-99.
27. Sica, G. L., Choi, I. H., Zhu, G., Tamada, K., Wang, S. D., Tamura, H., Chapoval, A. I. et al., B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 2003. 18: 849-861.
28. Koyama, M., Kuns, R. D., Olver, S. D., Raffelt, N. C., Wilson, Y. A., Don, A. L. J., Lineburg, K. E. et al., Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease. Nat. Med. 2011. 18: 135-142.
29. Zhang, Y., Louboutin, J.-P., Zhu, J., Rivera, A. J. and Emerson, S. G., Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease. J. Clin. Invest. 2002. 109: 1335-1344.
30. Toubai, T., Malter, C., Tawara, I., Liu, C., Nieves, E., Lowler, K. P., Sun, Y. et al., Immunization with host-type CD8{alpha}+ dendritic cells reduces experimental acute GVHD in an IL-10-dependent manner. Blood 2010. 115: 724-735.
31. Matte-Martone, C., Wang, X., Anderson, B., Jain, D., Demetris, A. J., McNiff, J., Shlomchik, M. J. et al., Recipient B cells are not required for graft-versus-host disease induction. Biol. Blood Marrow Transplant 2010. 16: 1222-1230.
32. Fehr, T., Haspot, F., Mollov, J., Chittenden, M., Hogan, T. and Sykes, M., Alloreactive CD8 T cell tolerance requires recipient B cells, dendritic cells, and MHC class II. J. Immunol. 2008. 181: 165-173.
33. Shimabukuro-Vornhagen, A., Hallek, M. J., Storb, R. F. and Bergwelt-Baildon von, M. S., The role of B cells in the pathogenesis of graft-versus-host disease. Blood 2009. 114: 4919-4927.
34. Michonneau, D., Peffault de Latour, R., Porcher, R., Robin, M., Benbunan, M., Rocha, V., Ribaud, P. et al., Influence of bone marrow graft B lymphocyte subsets on outcome after HLA-identical sibling transplants. Br. J. Haematol. 2009. 145: 107-114.
35. Le Huu, D., Matsushita, T., Jin, G., Hamaguchi, Y., Hasegawa, M., Takehara, K., Tedder, T. F. et al., Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease. Blood 2013. 121: 3274-3283.
36. Calderon-Gomez, E., Lampropoulou, V., Shen, P., Neves, P., Roch, T., Stervbo, U., Rutz, S. et al., Reprogrammed quiescent B cells provide an effective cellular therapy against chronic experimental autoimmune encephalomyelitis. Eur. J. Immunol. 2011. 41: 1696-1708.
37. Weber, M., Lupp, C., Stein, P., Kreft, A., Bopp, T., Wehler, T. C., Schmitt, E. et al., Mechanisms of Cyclic Nucleotide Phosphodiesterases in Modulating T Cell Responses in Murine Graft-versus-Host Disease. PLoS ONE. 2013. 8: e58110.